|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
MY140561A
(en)
|
2002-02-20 |
2009-12-31 |
Nycomed Gmbh |
Dosage form containing pde 4 inhibitor as active ingredient
|
|
DK1610787T3
(da)
*
|
2003-03-28 |
2008-06-02 |
Nycomed Gmbh |
Synergistisk kombination der omfatter roflumilast og et antikolinergt middel der er valgt blandt tiotropiumsalte til behandling af respiratoriske sygdomme
|
|
JP2006523674A
(ja)
*
|
2003-04-18 |
2006-10-19 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
慢性閉塞性肺疾患（ｃｏｐｄ）のための組合せ治療法
|
|
EA012279B1
(ru)
*
|
2003-05-22 |
2009-08-28 |
Никомед Гмбх |
Композиция, включающая ингибитор pde4 и ингибитор pde5
|
|
CA2534125A1
(en)
*
|
2003-07-29 |
2005-02-17 |
Boehringer Ingelheim International Gmbh |
Medicaments comprising pde iv inhibitors and an anticholinergic for treating respiratory disorders
|
|
EP1504756A1
(en)
*
|
2003-08-06 |
2005-02-09 |
Kyowa Hakko Kogyo Co., Ltd |
Medicament compositions comprising a heterocyclic compound and an anticholinergic
|
|
RU2006132043A
(ru)
*
|
2004-02-06 |
2008-03-20 |
МЕДА Фарма ГмбХ унд Ко.КГ (DE) |
Комбинация и фармацевтический препарат для лечения ринита
|
|
WO2005074982A2
(en)
*
|
2004-02-06 |
2005-08-18 |
Meda Pharma Gmbh & Co. Kg |
Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
|
|
EP1713473B1
(en)
|
2004-02-06 |
2013-03-13 |
MEDA Pharma GmbH & Co. KG |
The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and copd
|
|
EP1718304A1
(en)
*
|
2004-02-20 |
2006-11-08 |
Boehringer Ingelheim International GmbH |
Pharmaceutical compositions based on anticholinergics and pegsunercept
|
|
US7507745B2
(en)
|
2004-02-20 |
2009-03-24 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins
|
|
ATE474601T1
(de)
*
|
2004-05-31 |
2010-08-15 |
Almirall Sa |
Kombinationen mit antimuskarin-wirkstoffen und pde4-hemmern
|
|
ES2257152B1
(es)
*
|
2004-05-31 |
2007-07-01 |
Laboratorios Almirall S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
|
US20060079544A1
(en)
*
|
2004-08-13 |
2006-04-13 |
Boehringer Ingelheim International Gmbh |
Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
|
|
ES2570332T3
(es)
|
2005-03-16 |
2016-05-17 |
Meda Pharma Gmbh & Co Kg |
La combinación de anticolinérgicos y antagonistas del receptor de leucotrieno para el tratamiento de enfermedades respiratorias
|
|
WO2006118268A1
(ja)
*
|
2005-04-28 |
2006-11-09 |
Dainippon Sumitomo Pharma Co., Ltd. |
慢性閉塞性肺疾患治療剤
|
|
DE102005035112A1
(de)
*
|
2005-07-27 |
2007-02-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neues Verfahren zur Herstellung von Tiotropiumsalzen unter Anwendung von in organischen Lösungsmitteln löslichen N-Methylscopiniumsalzen
|
|
EP1928437A2
(en)
|
2005-08-26 |
2008-06-11 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation
|
|
EP2258358A3
(en)
|
2005-08-26 |
2011-09-07 |
Braincells, Inc. |
Neurogenesis with acetylcholinesterase inhibitor
|
|
EP1940389A2
(en)
|
2005-10-21 |
2008-07-09 |
Braincells, Inc. |
Modulation of neurogenesis by pde inhibition
|
|
US20070112017A1
(en)
|
2005-10-31 |
2007-05-17 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
|
NZ591969A
(en)
|
2005-12-21 |
2012-05-25 |
Meda Pharma Gmbh & Co Kg |
Combination of anticholinergics, glucocorticoids, beta2-adrenoceptor agonists, PDE 4 inhibitor and antileukotriene for the treatment of inflammatory diseases
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
AU2007249399A1
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
EP1905440A1
(de)
*
|
2006-09-06 |
2008-04-02 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Verwendung einer pharmazeutischen Zusammensetzung enthaltend ein Anticholinergikum zur Abtötung von Mikroorganismen und zur Behandlung von Atemwegsinfektionen
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
EP2100598A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
EP2100599A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
WO2010099217A1
(en)
|
2009-02-25 |
2010-09-02 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
EP3090999A1
(en)
|
2009-06-18 |
2016-11-09 |
Concert Pharmaceuticals Inc. |
Deuterated isoindoline-1, 3-dione derivatives as pde4 and tnf-alpha inhibitors
|
|
EP2510928A1
(en)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium for use in improving the quality of sleep in respiratory patients
|
|
WO2013106547A1
(en)
|
2012-01-10 |
2013-07-18 |
President And Fellows Of Harvard College |
Beta-cell replication promoting compounds and methods of their use
|